This project consists of testing new targeted therapies for glioblastoma, a highly aggressive brain cancer with very limited treatment options. The research focuses on antibody–drug conjugates that specifically bind to VEGFR-1, a protein found at high levels on glioblastoma cells and in the tumor environment. Once bound, these antibodies deliver potent cancer-killing drugs directly to […]
Read More